A potent neutralizing nanobody targeting a unique epitope on the receptor-binding domain of SARS-CoV-2 spike protein.
Zhang Y, Wang D, Xiang Q, Hu X, Zhang Y, Wu L, Zhang Z, Wang Y, Zhao J, McCormick PJ, Fu J, Fu Y, Zhang J, Jiang H, Li J.
Zhang Y, et al. Among authors: fu y, fu j.
Virology. 2024 Jan;589:109925. doi: 10.1016/j.virol.2023.109925. Epub 2023 Nov 14.
Virology. 2024.
PMID: 37984151
Free article.